DRUG INTERACTION STUDIES OF ATORVASTATIN AND OTHER DRUGS BASED ON BIOINFORMATICS. (8th October 2012)

• Record Type: Journal Article
• Authors: Gao, Yan; Fan, Li; Lu, Xue-Chun; Cao, Jian; Zhao, Xia; Pei, Jing; Meng, Xiao-yan; Fan, Li
• Is Part Of: Heart. Volume 98(2012)Supplement 2
• Page Start: E21
• Page End: E21
• Publication Date: 2012-10-08
• Subjects: Heart -- Diseases -- Treatment -- Periodicals; Cardiology -- Periodicals; 616.12
• DOI: 10.1136/heartjnl-2012-302920a.46
• Languages: English
• ISSNs: 1355-6037

Abstract

Abstract : Objectives: To explore the drug interactions between atorvastatin and other drugs based on bioinformatics. Methods: The human umbilical vein endothelial cell line EA. hy 926 cultured in vitro was incubated with atorvastatin (10 −5 mol/l) for 24 h. Total RNA from these cells was extracted and performed for gene expression profiling. The SAM microarray analysis software was used to analyse the differenced genes between the control and experiment groups. Gene set enrichment analysis (GSEA) was used for pathway analysis, and gene ontology (GO) analysis. The Connectivity Map (Cmap) was used to screen the interaction drugs with atorvastatin. Results: Compared with the control cells, 649 genes were detected to have marked changes with 295 up-regulated and 354 down-regulated expression in atorvastatin treated EA. hy 926 cells. 13 pathways including coagulation in upregulated gene expression and 113 pathways mainly enrichment in cell cycle in downregulated gene expression using GSEA showed statistical significance. In Cmap analysis the profile of the HDAC inhibitor MS-275, trichostatin A, Vorinostat and resveratrol, Phenothiazines derivatives were found to be highly similar to that of atorvastatin (p<0.001). Conclusions: The study of drug interactions based on the bioinformatics is feasible, atorvastatin have a synergistic effect with histone deacetylase inhibitors, resveratrol and phenothiazine derivatives.